MEDDYGFA EMLYN
LLOYDS TERRACE, ADPAR, NEWCASTLE EMLYN
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 132 | 157 | 84.1% | |
| CKD 4 | 2008 | 161 | 190 | 84.7% | |
| CKD 5 | 2009 | 5 | 6 | 83.3% | |
| CKD 5 | 2010 | 26 | 27 | 96.3% | |
| CKD 5 | 2011 | 29 | 31 | 93.5% | |
| CKD 5 | 2012 | 28 | 35 | 80.0% | |
| CKD 5 | 2013 | 30 | 34 | 88.2% | |
| CKD003W | 2014 | 16 | 17 | 94.1% |
